Skip to main content
logo
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.080
+0.020 (1.89%)
At close: Aug 18, 2026, 4:00 PM EDT
1.090
+0.010 (0.93%)
After-hours: Aug 18, 2026, 4:58 PM EDT

Telomir Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-5.88-10.41-16.53-13.07-0.85-0.14
Other Amortization
--4.341.61--
Stock-Based Compensation
0.926.136.87---
Other Operating Activities
---7.49--
Change in Accounts Payable
-0.06-0.050.180.110.390.02
Change in Other Net Operating Assets
0.10.65-0.06-0--
Operating Cash Flow
-4.91-3.69-5.07-3.86-0.47-0.12
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.16-3.120.460.12
Total Debt Issued
0.380.16-3.120.460.12
Short-Term Debt Repaid
---0.1---
Total Debt Repaid
-0.24--0.1---
Net Debt Issued (Repaid)
0.140.16-0.13.120.460.12
Issuance of Common Stock
8.519.556.8710.06-
Other Financing Activities
0.68--0.43-0.26-0.05-
Financing Cash Flow
9.339.716.343.860.470.12

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
4.426.021.26-00-

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
2.14-0.091.1-1.96--
Unlevered Free Cash Flow
2.15-0.09-0.53-2.55--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.050.590.130.110.390.02
SEC Filings: 10-K · 10-Q